Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wednesday, August 14, 2013 - 9:13am
tags:
lung cancer, Eli Lilly, necitumumab, non-small cell lung cancer
[video]Time to Panic About Pfizer's Upcoming Patent Expirations?
Motley Fool
Wednesday, August 14, 2013 - 9:11am
tags:
patents, Pfizer
2 Biotechs Aim To Capitalize On The Treatment Of Melanoma
Seeking Alpha
Tuesday, August 13, 2013 - 4:13pm
tags:
melanoma, Amgen, OncoSec, Vical, TVEC, NeoPulse
Osiris shares rocket, company details Grafix study
Yahoo/AP
Tuesday, August 13, 2013 - 4:09pm
tags:
Grafix, Osiris Therapeutics, diabetes, diabetic foot ulcers
Report: Novartis Bails on Onyx Bid
Barron's
Tuesday, August 13, 2013 - 4:06pm
tags:
Novartis, ONYX Pharmaceuticals, M&A
The Next Big Opportunity in Antidepressant Drugs
Motley Fool
Tuesday, August 13, 2013 - 11:08am
tags:
antidepressants, Pfizer, Eli Lilly, Forest Labs, Cymbalta, Fetzima, Pristiq, major depressive disorder
Is This Biotech Stock Worth Buying After a Massive Post-IPO Surge?
Motley Fool
Tuesday, August 13, 2013 - 11:06am
tags:
IPOs, Intrexon, Eli Lilly, synthetic DNA
Acasti announces positive phase 2 open label clinical trial result
The Fly on the Wall
Tuesday, August 13, 2013 - 11:04am
tags:
Acasti, clinical trials, CaPre, hypertriglyceridemia
ZS Associates: What do pharma reps need to get face time with doctors?
Fierce Pharma
Tuesday, August 13, 2013 - 11:03am
tags:
physicians, drug reps
LAT: Purdue keeps 'risky' OxyContin prescribers' names private
Fierce Pharma
Tuesday, August 13, 2013 - 11:01am
tags:
Purdue Pharma, physicians, oxycontin
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tuesday, August 13, 2013 - 11:00am
tags:
Alexion, BiogenIdec, Santarus, Regeneron
Biota Pharma's Game-Changer, Laninamivir: Are You Ready For The Next Pandemic Flu?
Seeking Alpha
Tuesday, August 13, 2013 - 10:56am
tags:
Biota, Laninamivir, Flu, antivirals
NPS Pharmaceuticals Has A Billion Plus Blockbuster On Its Hands
Seeking Alpha
Tuesday, August 13, 2013 - 10:55am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Amarin advances after firm raises rating on shares
The Fly on the Wall
Tuesday, August 13, 2013 - 10:53am
tags:
Amarin, Vascepa
Orexigen Investigated By Class Action Firm
Seeking Alpha
Tuesday, August 13, 2013 - 10:51am
tags:
Orexigen, Class Action Lawsuit
Lower-than-Expected Loss at OncoGenex
Yahoo/Zacks
Tuesday, August 13, 2013 - 10:49am
tags:
earnings, OncoGenex
Eli Lilly Lung Cancer Drug Raises Patient Survival in Trial
Bloomberg
Tuesday, August 13, 2013 - 10:48am
tags:
necitumumab, Eli Lilly, lung cancer
Why Is Novartis in Trouble in Japan?
Wall St. Cheat Sheet
Tuesday, August 13, 2013 - 10:47am
tags:
Japan, Novartis, Diovan
Avanir Pharma to co-promote Merck's diabetes drugs; shares rise
Reuters
Tuesday, August 13, 2013 - 10:42am
tags:
Avanir, Merck, diabetes, Januvia, Janumet, Janumet XR
ADHD Drug Emergencies Quadrupled In 6 Years, Says Government Report
Forbes
Tuesday, August 13, 2013 - 10:05am
tags:
ADHD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.